Metabologenomics approach to the discovery of novel compounds from Streptomyces sp. GMR22 as anti-SARS-CoV-2 drugs

COVID-19 is spreading rapidly yet there is no clinically proven drug available now. Soil-derived Streptomyces sp. GMR22 has a large genome size (11.4 Mbp) and a huge BGCs (Biosynthetic Gene Clusters) encoding secondary metabolites. This bacterium is a potential source for producing a wide variety of...

Descripción completa

Detalles Bibliográficos
Autores principales: Melinda, Yohana Nadia, Widada, Jaka, Wahyuningsih, Tutik Dwi, Febriansah, Rifki, Damayanti, Ema, Mustofa, Mustofa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560767/
https://www.ncbi.nlm.nih.gov/pubmed/34746476
http://dx.doi.org/10.1016/j.heliyon.2021.e08308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560767/
https://www.ncbi.nlm.nih.gov/pubmed/34746476
http://dx.doi.org/10.1016/j.heliyon.2021.e08308

Ejemplares similares